PH27608A - Polyamines useful as antagonists of excitatory amino acid neurotransmitters - Google Patents

Polyamines useful as antagonists of excitatory amino acid neurotransmitters

Info

Publication number: PH27608A
Authority: PH; Philippines
Prior art keywords: amino acid; excitatory amino; neurotransmitters; antagonists; polyamines useful
Prior art date: 1990-01-02

Application number

PH41752A

Other languages

English (en)

Inventor

Nicholas Alex Saccomano

Robert Alredo Vaokmann

Original Assignee

Pfizer

Natural Product Sciences Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-01-02

Filing date

1990-12-19

Publication date

1993-08-18

1990-12-19 Application filed by Pfizer, Natural Product Sciences Inc filed Critical Pfizer

1993-08-18 Publication of PH27608A publication Critical patent/PH27608A/en

Links

239000002858 neurotransmitter agent Substances 0.000 title abstract 5
230000002461 excitatory amino acid Effects 0.000 title abstract 3
239000003257 excitatory amino acid Substances 0.000 title abstract 3
229920000768 polyamine Polymers 0.000 title abstract 2
239000005557 antagonist Substances 0.000 title 1
241000238898 Agelenopsis aperta Species 0.000 abstract 1
241000607479 Yersinia pestis Species 0.000 abstract 1
230000003042 antagnostic effect Effects 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
230000001404 mediated effect Effects 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
239000002435 venom Substances 0.000 abstract 1
210000001048 venom Anatomy 0.000 abstract 1
231100000611 venom Toxicity 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Neurosurgery (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurology (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Hospice & Palliative Care (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Polyamides (AREA)
Indole Compounds (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)

PH41752A 1990-01-02 1990-12-19 Polyamines useful as antagonists of excitatory amino acid neurotransmitters PH27608A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US46020790A	1990-01-02	1990-01-02
US07/560,699 US5037846A (en)	1990-01-02	1990-07-31	Indolyl-3 polyamines and their use as antagonists of excitatory amino acid neurotransmitters

Publications (1)

Publication Number	Publication Date
PH27608A true PH27608A (en)	1993-08-18

Family

ID=27039601

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PH41752A PH27608A (en)	1990-01-02	1990-12-19	Polyamines useful as antagonists of excitatory amino acid neurotransmitters

Country Status (23)

Country	Link
US (1)	US5037846A (de)
EP (1)	EP0436332B1 (de)
JP (1)	JPH0714913B2 (de)
KR (1)	KR930007250B1 (de)
CN (1)	CN1053059A (de)
AT (1)	ATE133941T1 (de)
AU (2)	AU619700B2 (de)
CA (1)	CA2033480C (de)
DE (1)	DE69025305T2 (de)
DK (1)	DK0436332T3 (de)
ES (1)	ES2083439T3 (de)
FI (1)	FI93644C (de)
GR (1)	GR3019487T3 (de)
HU (1)	HUT56063A (de)
IE (1)	IE70757B1 (de)
IL (1)	IL96793A0 (de)
MY (1)	MY104588A (de)
NO (1)	NO173733C (de)
NZ (1)	NZ236550A (de)
PH (1)	PH27608A (de)
PL (1)	PL165647B1 (de)
PT (1)	PT96389A (de)
YU (1)	YU247590A (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5227397A (en) *	1989-04-28	1993-07-13	Pfizer Inc.	Polyamines and polypeptides useful as antagonists of excitatory amino acid neuro-transmitters and/or as blockers of calcium channels
US5037846A (en) *	1990-01-02	1991-08-06	Pfizer Inc.	Indolyl-3 polyamines and their use as antagonists of excitatory amino acid neurotransmitters
US5312928A (en) *	1991-02-11	1994-05-17	Cambridge Neuroscience	Calcium channel antagonists and methodology for their identification
US5677288A (en) *	1991-05-15	1997-10-14	Cypros Pharmaceutical Corporation	Use of aminoglycosides to protect against excitotoxic neuron damage
BR9206403A (pt) *	1991-08-23	1994-12-27	Pfizer	Aril-poliaminas sintéticas como antagonistas de neurotransmissores aminoácidos excitadores
US5185369A (en) *	1991-08-23	1993-02-09	Pfizer Inc.	Synthetic heteroaryl polyamines as excitatory amino acid neurotransmitter antagonists
US5763568A (en) *	1992-01-31	1998-06-09	Zeneca Limited	Insecticidal toxins derived from funnel web (atrax or hadronyche) spiders
US6750244B2 (en)	1993-02-08	2004-06-15	Nps Pharmaceuticals, Inc.	Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
US6017965A (en) *	1993-02-08	2000-01-25	Nps Pharmaceuticals, Inc.	Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
US6071970A (en) *	1993-02-08	2000-06-06	Nps Pharmaceuticals, Inc.	Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
US7087765B2 (en)	1995-06-07	2006-08-08	Nps Pharmaceuticals, Inc.	Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
US6211245B1 (en)	1993-02-08	2001-04-03	Nps Pharmaceuticals, Inc.	Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
DE69434889D1 (de)	1994-02-08	2007-01-11	Nps Pharma Inc	An einer neuen Stelle von Rezeptorabhängigen Kalziumkanälen wirkende Verbindungen zur Behandlung von neurologischen Erkrankungen
US5688764A (en) *	1995-02-17	1997-11-18	Nps Pharmaceuticals, Inc.	Insecticidal peptides from spider venom
US5874298A (en) *	1995-02-17	1999-02-23	Nps Pharmaceuticals, Inc.	Insecticidal toxins from Bracon hebetor nucleic acid encoding said toxin and methods of use
US5674846A (en) *	1996-09-04	1997-10-07	Nps Pharmaceuticals, Inc.	Insecticidal peptides from Segestria sp. spider venom
WO1998036743A1 (en) *	1997-02-21	1998-08-27	Cypros Pharmaceutical Corporation	Neuroprotective poly-guanidino compounds which block presynaptic n and p/q calcium channels
US7087648B1 (en)	1997-10-27	2006-08-08	The Regents Of The University Of California	Methods for modulating macrophage proliferation using polyamine analogs
AU2003231670B2 (en) *	1997-10-27	2006-06-08	Slil Biomedical Corporation	Methods for modulating macrophage proliferation using polyamine analogs
US8198334B2 (en) *	1997-10-27	2012-06-12	Pathologica Llc	Methods for modulating macrophage proliferation in ocular disease using polyamine analogs
WO2002053519A2 (en) *	2001-01-08	2002-07-11	Mediquest Therapeutics, Inc.	Hydrophobic polyamine analogs and methods for their use
JP2005510524A (ja)	2001-11-16	2005-04-21	アルス・セラピー・デベロツプメント・フアンデーシヨン・インコーポレーテツド	ポリアミン経路の調節による神経変性障害の治療
EP1448183A2 (de) *	2001-11-16	2004-08-25	ALS Therapy Development Foundation, Inc.	Behandlung von neurodegenerativen erkrankungen durch modulieren des polyaminenbiosynthesewegs
BRPI0517551A (pt) *	2004-10-04	2008-10-14	Cellgate Inc	análogos de poliamina como agentes terapêuticos para doenças oculares
CN101300004B (zh) *	2005-09-23	2013-08-21	帕瑟洛吉卡有限公司	使用多胺类似物治疗病毒感染的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4925664A (en) *	1986-10-20	1990-05-15	University Of Utah	Spider toxins and methods for their use as blockers of calcium channels and amino acid receptor function
IT1206078B (it) *	1987-06-03	1989-04-14	Polifarma Spa	Procedimento per la produzione di acido 3-indolpiruvico e suoi derivati loro uso farmaceutico
US4950739A (en) *	1988-02-10	1990-08-21	New York University	Membrane calcium channels and factors and methods for blocking, isolating and purifying calcium channels
DD298412A5 (de) *	1989-04-28	1992-02-20	��@��Kk��	Verfahren zur herstellung von polypeptiden, die geeignet sind als antagonisten exzitatorischer aminosaeure-neurotransmitter und/oder blocker der calciumkanaele
US5037846A (en) *	1990-01-02	1991-08-06	Pfizer Inc.	Indolyl-3 polyamines and their use as antagonists of excitatory amino acid neurotransmitters

1990
- 1990-07-31 US US07/560,699 patent/US5037846A/en not_active Expired - Lifetime
- 1990-12-14 AT AT90313663T patent/ATE133941T1/de not_active IP Right Cessation
- 1990-12-14 DE DE69025305T patent/DE69025305T2/de not_active Expired - Lifetime
- 1990-12-14 ES ES90313663T patent/ES2083439T3/es not_active Expired - Lifetime
- 1990-12-14 EP EP90313663A patent/EP0436332B1/de not_active Expired - Lifetime
- 1990-12-14 DK DK90313663.8T patent/DK0436332T3/da active
- 1990-12-19 NZ NZ236550A patent/NZ236550A/en unknown
- 1990-12-19 PH PH41752A patent/PH27608A/en unknown
- 1990-12-26 IL IL96793A patent/IL96793A0/xx unknown
- 1990-12-27 PL PL90288490A patent/PL165647B1/pl unknown
- 1990-12-28 JP JP2418815A patent/JPH0714913B2/ja not_active Expired - Lifetime
- 1990-12-28 NO NO905616A patent/NO173733C/no unknown
- 1990-12-28 YU YU247590A patent/YU247590A/sh unknown
- 1990-12-28 PT PT96389A patent/PT96389A/pt not_active Application Discontinuation
- 1990-12-28 AU AU68561/90A patent/AU619700B2/en not_active Ceased
- 1990-12-29 HU HU908509A patent/HUT56063A/hu unknown
- 1990-12-29 MY MYPI90002301A patent/MY104588A/en unknown
- 1990-12-31 FI FI906466A patent/FI93644C/fi active IP Right Grant
- 1990-12-31 CN CN90110248A patent/CN1053059A/zh active Pending
- 1990-12-31 KR KR1019900022585A patent/KR930007250B1/ko not_active Expired - Fee Related
- 1990-12-31 IE IE473490A patent/IE70757B1/en not_active IP Right Cessation
- 1990-12-31 CA CA002033480A patent/CA2033480C/en not_active Expired - Lifetime
1992
- 1992-04-30 AU AU15926/92A patent/AU640565B2/en not_active Ceased
1996
- 1996-04-02 GR GR960400875T patent/GR3019487T3/el unknown

Also Published As

Publication number	Publication date
NO173733C (no)	1994-01-26
ES2083439T3 (es)	1996-04-16
NO905616L (no)	1991-07-03
KR910014123A (ko)	1991-08-31
US5037846A (en)	1991-08-06
FI906466L (fi)	1991-07-03
NZ236550A (en)	1992-05-26
PL165647B1 (pl)	1995-01-31
AU1592692A (en)	1992-07-09
IE70757B1 (en)	1996-12-30
YU247590A (sh)	1993-10-20
CA2033480A1 (en)	1991-07-03
FI906466A0 (fi)	1990-12-31
NO905616D0 (no)	1990-12-28
FI93644B (fi)	1995-01-31
EP0436332A2 (de)	1991-07-10
MY104588A (en)	1994-04-30
IE904734A1 (en)	1991-07-17
JPH04210677A (ja)	1992-07-31
GR3019487T3 (en)	1996-07-31
DE69025305T2 (de)	1996-06-27
AU619700B2 (en)	1992-01-30
AU640565B2 (en)	1993-08-26
CA2033480C (en)	1995-11-21
PT96389A (pt)	1991-10-15
DK0436332T3 (da)	1996-03-11
FI93644C (fi)	1995-05-10
HUT56063A (en)	1991-07-29
KR930007250B1 (ko)	1993-08-04
PL288490A1 (en)	1991-12-16
DE69025305D1 (de)	1996-03-21
EP0436332A3 (en)	1991-09-25
AU6856190A (en)	1991-07-04
NO173733B (no)	1993-10-18
JPH0714913B2 (ja)	1995-02-22
IL96793A0 (en)	1991-09-16
ATE133941T1 (de)	1996-02-15
CN1053059A (zh)	1991-07-17
EP0436332B1 (de)	1996-02-07

Publication	Publication Date	Title
PH27608A (en)	1993-08-18	Polyamines useful as antagonists of excitatory amino acid neurotransmitters
CA2015505A1 (en)	1990-10-28	Polyamines and polypeptides useful as antagonists of excitatory amino acid neurotransmitters and/or as blockers of calcium channels
FI112471B (fi)	2003-12-15	Menetelmä uusien terapeuttisesti käyttökelpoisten hydroksietyyliaminosulfoniamidien valmistamiseksi
HUT46708A (en)	1988-11-28	Process for producing heterocyclic ketones and pharmaceutical compositions containing them as active components
OA09982A (fr)	1996-03-29	Derives heterocycliques leur procede de production et composition pharmaceutique les contenant
AU621483B2 (en)	1992-03-12	Azaindenes
AU6320394A (en)	1994-12-15	Aryl substituted heterocycles
NO20001764L (no)	2000-06-13	FremgangsmÕte for fremstilling av melkesyre, og syretolerant homolaktisk bakterie
DE3875792D1 (de)	1992-12-17	Neues herbizid, seine herstellung und seine verwendung.
FI895185A0 (fi)	1989-11-01	Mevalonolaktoner av tienopyridintyp.
HUT55036A (en)	1991-04-29	Process for producing polypeptides blocking the calcium duct
FI101301B1 (fi)	1998-05-29	Menetelmä terapeuttisesti käyttökelpoisten, N-substituoitujen heksahydroatsepiinijohdannaisten valmistamiseksi
FI893682A0 (fi)	1989-08-03	Menetelmä terapeuttisesti käyttökelpoisten 1,2,5-ditiatsosiinijohdannaisten valmistamiseksi
DE69503093D1 (de)	1998-07-30	Verfahren zur Herstellung von Guaniden
HU9303505D0 (en)	1994-04-28	Process for producing organic compound
ATE110730T1 (de)	1994-09-15	Verfahren zur herstellung von cephalosporinen.